Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Merkel Cell × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 5 Lung Neoplasms 4 Prostatic Neoplasms 3 Motor Activity 2 Hodgkin Disease 2 Hematopoietic and Lymphoid System Neoplasm 2 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Sedentary Behavior 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pathologically Proven Gastrointestinal Malignancy 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Insulin Resistance 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Fatigue 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Depression 1 Colonic Neoplasms 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Cardiotoxicity 1 Carcinoma, Transitional Cell 1

Interventions

Surgical Procedures, Operative 1 Radiotherapy 1 Exercise Test 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008977 2025-06-04

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡